NYSE$ECL
Ecolab Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Ecolab demonstrated continued strong growth, with adjusted diluted EPS increasing by 19% and the full-year adjusted diluted EPS outlook raised.
Ecolab reported a 1% increase in sales to $4.0 billion, including a 2% headwind from the sale of the global surgical solutions business and a 1% headwind from currency exchange. Organic sales grew by 4%, driven by volume growth and value pricing. Adjusted diluted EPS increased by 19% to $1.83, and the company increased its full-year adjusted diluted EPS outlook to $6.60 - $6.70.
- Reported sales increased by 1% to $4.0 billion, including headwinds from the sale of the global surgical solutions business and currency exchange.
- Organic sales grew by 4%, with volume growth strengthening to 2% and value pricing in the targeted 2-3% range.
- Reported operating income margin was 26.1%, while organic operating income margin increased by 260 bps to 17.9%.
- Adjusted diluted EPS increased by 19% to $1.83, excluding special gains and charges and discrete tax items.
Headline financials
Revenue & EPS history
Ecolab · Revenue · Quarterly
$4B
Revenue by segment
Ecolab · $1.31B total across 1 segment · Q3 2023
- Global Institutional & Specialty$1.31B+12.9%100.0%
Forward guidance
Ecolab anticipates a robust conclusion to the year and expects to drive 12-15% growth in adjusted diluted earnings per share in 2025 and beyond.
Tailwinds
- Continued solid sales growth driven by value pricing and new business gains.
- Attractive organic operating income margin expansion.
- Robust increases in gross margin.
- Good underlying productivity improvement.
- Stable macroeconomic demand.
Headwinds
- Growth-oriented investments in the business to fuel Ecolab’s long-term performance.
- Unfavorable $0.08 per share impact in the second half of 2024 from the sale of the global surgical solutions business.
- Favorability from lower raw material costs has progressively eased through the third quarter of 2024.
- Raw material costs are anticipated to be stable to slightly higher in the fourth quarter of 2024.
- Quantifiable special charges in the fourth quarter of 2024 to be approximately $0.13 per share, principally related to restructuring charges.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
+0.1%
Avg return
Earnings day
-0.0%
Avg return
5 days after
+1.3%
Avg return
30 days after
58%
42 / 73 earnings
Positive
+10.9%
Q4 2022
Best reaction
-12.6%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.8% | -3.1% | -3.1% | |
| Q4 2025 | +4.0% | +3.8% | -4.3% | |
| Q3 2025 | -4.1% | -8.3% | -1.7% | |
| Q2 2025 | +0.4% | +2.9% | +1.8% | |
| Q1 2025 | +3.3% | +6.8% | +10.6% | |
| Q4 2024 | +6.2% | +7.6% | +2.1% | |
| Q3 2024 | -1.5% | -4.6% | -3.4% | |
| Q2 2024 | -6.9% | -4.3% | +0.9% | |
| Q1 2024 | +1.5% | +2.6% | +3.2% | |
| Q4 2023 | +6.9% | +1.7% | -1.4% | |
| Q3 2023 | +5.1% | +9.8% | +20.5% | |
| Q2 2023 | +1.0% | -0.3% | +0.4% | |
| Q1 2023 | +2.7% | +2.9% | +0.2% | |
| Q4 2022 | +10.9% | +9.8% | +7.4% | |
| Q3 2022 | -12.6% | -14.2% | -3.3% | |
| Q2 2022 | -1.3% | +1.5% | +5.0% | |
| Q1 2022 | -2.9% | -3.6% | -6.5% | |
| Q4 2021 | -0.1% | -2.3% | -6.1% | |
| Q3 2021 | -0.2% | +0.3% | +4.4% | |
| Q2 2021 | -0.0% | +0.8% | +1.8% | |
| Q1 2021 | -2.1% | -1.2% | -4.7% | |
| Q4 2020 | -5.0% | -5.4% | -4.7% | |
| Q3 2020 | -6.5% | -7.4% | +10.0% | |
| Q2 2020 | -8.1% | -11.8% | -6.8% | |
| Q1 2020 | +5.4% | +1.3% | +12.7% | |
| Q4 2019 | +1.4% | +0.1% | -23.0% | |
| Q3 2019 | +1.1% | -0.3% | -2.4% | |
| Q2 2019 | +0.6% | -0.3% | +3.2% | |
| Q1 2019 | -1.1% | +0.3% | -0.6% | |
| Q4 2018 | +1.1% | +2.2% | +7.5% | |
| Q3 2018 | +4.5% | +5.5% | +8.1% | |
| Q2 2018 | +2.8% | +4.5% | +6.7% | |
| Q1 2018 | -0.4% | +0.4% | -1.5% | |
| Q4 2017 | -1.2% | -0.5% | +2.0% | |
| Q3 2017 | +0.3% | +0.4% | +3.8% | |
| Q2 2017 | +0.9% | +0.9% | +1.2% | |
| Q1 2017 | -2.8% | -2.2% | +3.5% | |
| Q4 2016 | -0.7% | +1.3% | +0.2% | |
| Q3 2016 | -1.9% | -3.1% | +3.8% | |
| Q2 2016 | +2.3% | +3.4% | +3.7% | |
| Q1 2016 | +0.9% | — | — | |
| Q4 2015 | -5.5% | — | — | |
| Q3 2015 | -0.3% | — | — | |
| Q2 2015 | +6.4% | — | — | |
| Q1 2015 | -1.4% | — | — | |
| Q4 2014 | +3.8% | — | — | |
| Q3 2014 | -2.2% | — | — | |
| Q2 2014 | -1.5% | — | — | |
| Q1 2014 | -0.9% | — | — | |
| Q4 2013 | +0.5% | — | — | |
| Q3 2013 | +3.0% | — | — | |
| Q2 2013 | +0.0% | — | — | |
| Q1 2013 | +1.2% | — | — | |
| Q4 2012 | +6.2% | — | — | |
| Q3 2012 | +0.1% | — | — | |
| Q2 2012 | -3.6% | — | — | |
| Q1 2012 | +1.0% | — | — | |
| Q4 2011 | -4.2% | — | — | |
| Q3 2011 | -4.6% | — | — | |
| Q2 2011 | -3.5% | — | — | |
| Q1 2011 | +2.5% | — | — | |
| Q4 2010 | +2.4% | — | — | |
| Q3 2010 | +0.3% | — | — | |
| Q2 2010 | -0.7% | — | — | |
| Q1 2009 | -1.7% | — | — | |
| Q1 2010 | +1.2% | — | — | |
| Q4 2007 | +0.5% | — | — | |
| Q4 2009 | +0.5% | — | — | |
| Q3 2009 | +2.2% | — | — | |
| Q3 2008 | +2.2% | — | — | |
| Q2 2009 | +0.0% | — | — | |
| Q2 2008 | +0.0% | — | — | |
| Q4 2008 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro